TWI Pharmaceuticals – FDA Inspection, Dec 2, 2016

Record Details

This FDA Inspection record concerns TWI Pharmaceuticals, with an inspection on December 2, 2016, issued by the Office of Inspections and Investigations, covering human drugs.

Company: TWI Pharmaceuticals
Inspection Date: December 2, 2016
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Arindam Dasgupta (Company Rep)
Nicola M. Fenty-Stewart (Issuing Officer)

View Company Profile

ID · 5950f027-dcb5-4ab7-95bc-01d9e0ea3574

Inspection Facts

Inspection number: 1042233
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore TWI Pharmaceuticals

FDA Inspection

TWI PharmaceuticalsDecember 2, 2016

TWI Pharmaceuticals – FDA Inspection, Dec 2, 2016

Record Details

This FDA Inspection record concerns TWI Pharmaceuticals, with an inspection on December 2, 2016, issued by the Office of Inspections and Investigations, covering human drugs.